LBA41 Phase II study SECOMBIT (sequential combo immuno and target therapy study): 4-years OS data and preliminary biomarkers evaluation

Authors :: P.A. Ascierto
M. Mandala
P.F. Ferrucci
M. Guidoboni
P. Rutkowski
V. Ferraresi
A.M. Arance Fernandez
M. Guida
E. Maiello
H.J. Gogas
E. Richtig
M.T. Fierro
C. Lebbe
H. Helgadottir
I. Melero
G. Palmieri
D. Giannarelli
A.M. Grimaldi
R. Dummer
V. Chiarion Sileni
Source :: Annals of Oncology. 33:S1408-S1409
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools